Guide for Authors
Section 1 Scope
This journal welcomes articles of basic research, clinical research, case reports, lectures, reviews, and nursing in all fields of geriatric medicine. The articles for the Expert Forum are mainly commissioned.
Section 2 Requirements for Manuscripts
1. Manuscripts should be scientific and practical, with clear argument, reliable information, concise text, clear structure, accurate data, and smooth and standardized writing. For articles of basic research, clinical research, nursing research, reviews, and lectures, the length should not exceed 6000 Chinese characters, including charts and references (based on pages). Case reports should not exceed 2500 Chinese characters.
2. Title: Title should be concise and clear, reflecting the theme of the article.
3. Authors: Author names are arranged in order under the article title, and authors' affiliations and postal codes are footnoted in the bottom left corner of the same page. If the corresponding author is not the first author, the corresponding author should be indicated in the bottom left corner of the title page.
4. Abstract: Research articles must be accompanied by a Chinese and English abstract, which must include four parts: objective, methods, results (main data should be provided), and conclusion. The English abstract should include the title, author names (in Chinese Pinyin, with each letter of surnames capitalized), affiliations, cities, postal codes, and countries.
5. Keywords: Research articles should be marked with 3 to 8 keywords.
6. Medical Terminology: Terminology should comply with the Medical Terminology approved by the National Science and Technology Terminology Approval Committee (National Natural Science Terminology Approval Committee) in 1989 and published by Science Press. For terms not covered, the English Chinese Medical Vocabulary published by the People's Health Publishing House shall prevail. Chinese drug names should adopt the names from the 1995 edition of Pharmacopoeia (statutory drugs) or the Vocabulary of Drug Names edited by the Pharmacopoeia Committee of the Ministry of Health (non-statutory drugs), while English drug names should adopt international non-patented drug names instead of trade names.
7. Figures and Tables: Each figure/table is encoded consecutively in the order it appears in the main body text. Even there is only one figure or table in the article, it should be encoded as Figure 1 / Table 1. Each figure or table should be accompanied by a heading. Annotations should be placed below the figure of table, and all non-public abbreviations should be indicated in annotations. This journal adopts a three-line style for tables (top line, head line, and bottom line).
8. Unit of Measurement: The Legal Measurement Units of the People's Republic of China promulgated by the State Council in February 1984 should be implemented, and the units should be represented with correct symbols.
9. Numbers: GB/T15835-1995 General rules for writing numerals in public texts should be implemented. The Arabic numerals should be adopted for the numbers in century, year, month, day, time, counting, and measurement.
10. Statistical Symbols: Statistical symbols should comply with relevant provisions of GB 3358-82 Statistical Terms and Symbols.
11. Abbreviations: Abbreviations are generally not used in title. When they must be used in the main body text, the full Chinese name should be stated at the first appearance, and then the Chinese abbreviation, or English full name and abbreviation should be indicated in parentheses. The latter two should be separated by "," (if the abbreviation is commonly known, its full English name can be omitted). Abbreviations cannot be break in different lines.
12. References: According to GB 7714-87 Rules for Content, Form and Structure of Bibliographic References, the sequential coding system is used for citation, and Arabic numerals and square brackets are used to indicate the order in which they appear in the text with corner codes. The authors in the references are listed in alphabetical order, with their surnames coming first and given names following. For articles with more than 3 authors, only the first 3 authors are listed, followed by "etc." Abbreviations could be used for foreign journal names, following the standard of Index Medicus. Chinese journals should include full names. Each reference must have a starting and ending page. References must be double-checked against their original text for accuracy. The references should be arranged in the order of citation (marked with Arabic numerals) at the end of the text.
13. Funding: The funding projects of each article should be footnoted at the bottom left corner of the title page, and a copy of project certificate should be attached. Articles supported by the National Natural Science Foundation and the Provincial Natural Science Foundation will be published in fast-track.
14. The submission must be accompanied by a recommendation letter from the author’s affiliation. The recommendation letter should include the review comments on the manuscript, and certifies that the article is not involved in multiple submission, confidential breach, or disputed authorship.
Section 3 Ethics Requirement
1. Plagiarism: This journal strictly prohibits multiple submission, redundant submitting (including submitting in different languages), or plagiarizing articles written by others. According to the Copyright Law, your manuscript is under review once a notice of receipt is sent to you, and the authors should not submit the article to another journal. This journal adopts the plagiarism detection system developed by China National Knowledge Infrastructure (CNKI) to check all manuscripts, with a maximum allowed repetition rate of 20%. Articles involved in academic misconduct will be rejected, and submissions from relevant authors will no longer be accepted thereafter.
2. Authorship: The order of authors should be determined at the time of submission and should not be changed during the editing process. Authors should be those who:
a) participated in topic selection and design, or in data analysis and interpretation:
b) drafted or revised key theories or other main content in the paper;
c) can review and revise the revision suggestions, and act as an academic defender.
The authors should specify their contribution in the Authors Contribution Form and submit it to the journal.
3. Medical Ethics: The ethical issue and informed consent of the study must comply with common principles of medical ethics. When research participants are humans, the author should explain whether its procedure comply with the ethical standards formulated by relevant committee (institutional, regional or national) responsible for human trials. The approval document of the committee should be submitted (the approval number should be included in the article). Consent letter from research participants or their relatives must be obtained, but not submitted to the editorial office. When reporting animal experiments, the study should comply with guidelines published by relevant committee on animal rights, and the approval document should be submitted.
4. Trial Registration: Clinical trials must include the Universal Trial Number (UTN) obtained from one of the Primary Registries in the WHO Registry Network. If applicable, the authors should specify the registering institution and the UTN within the article. The articles reporting randomized controlled trials shall comply with the standard of the CONSORT statement (http://www.consort-statement.org/home).
5. Conflict of Interest: All authors must disclose all potential conflicts of interest, i.e., when the financing/personal status/affiliation of the authors (or the authors' organization/employer) may affect the authors' decision, work or manuscript. When a product is mentioned, the authors should also disclose whether there is a conflict of interest against competitive products. The authors should disclose their competing interests in Authors Statement Form and submit it to the journal.
Section 4 Copyright Policy
1 Practical Geriatrics flipped to an open access journal since the 1st issue of 2025. Once published, all articles will be immediately and permanently available for readers to read and download free of charge. Some articles published before 2025 can be downloaded from this website free of charge, but these are not open access articles.
2 For all open access articles published by this journal, permitted authors and third-party reuse of the articles is defined by the following user license: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND 4.0). This license allows reusers to copy and redistribute the material in any medium or format. The licensor cannot revoke these freedoms as long as the license terms below are followed: reusers must give appropriate credit, provide a link to the license, and indicate if changes were made. Reusers may do so in any reasonable manner, but not in any way that suggests the licensor endorses the use. Reusers may not use the material for commercial purposes. If reusers remix, transform, or build upon the material, they may not distribute the modified material. The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/
3 Once the article submitted for publication in the journal is accepted, the authors transfer all copyrights of the entire article and any attached figures, tables, abstracts, or other parts that can be extracted from the article, to the editorial office of the journal, including but not limited to reproduction right, distribution right, information network broadcasting right, performance right, translation right, compilation right, adaptation right, etc. The authors may use the article under the CC BY-NC-ND 4.0 license, and may cite or translate parts of the article in their subsequent works, or compile it in their non-journal collection.
4 All journal articles published by this journal since 2010 have been digitally archived. The hard and soft copy of each issue of the journal had been kept in the editorial office for archiving. In order to ensure data security, all information and relevant materials, such as supplementary information and forms provided by the authors are backed up in the editorial office. The journal’s articles can also be downloaded in full text from databases including CNKI, Wanfang and Weipu.
Section 5 Editorial Policy
1. Self-Responsibility: Authors are responsible for their own writing. According to the provisions of the Copyright Law, this journal may make textual modifications or deletions to submitted manuscripts. Any modifications that involve the change of original meaning shall be submitted to the authors for confirm.
2. Review System: This journal implements double-blind review system. After submission, the manuscripts shall be registered and reviewed by editors (to determine whether it meets the requirements of our journal), and then sent to peer experts for review (to evaluate the academic level by 2-3 peer review experts). Authors must respond to the reviewer's comments term by term and submit a revised version of the manuscript. If the revised manuscript is not returned within one month, it will be considered as automatically withdrawn. The final decision on the acceptance of the manuscript is made by the director of the editorial office (rejected or need revision).
3. Internal Submission: Submissions by Editorial Board Members (EBMs)/Editors must adhere to the journal's review and editorial procedures, ensuring independence from the involved individuals and their research groups. They cannot participate in reviews of manuscripts whose authors they have conflicts of interest with.
4. Special Topic: This journal does not publish supplementary issues or special issues. Each issue has a column of Expert forum, where excellent papers will be published under the same strict review system to ensure quality.
5. Correction and Retraction: After publishing, if there appears to be an unintended scientific mistake in the article which would not lead to significant impacts on the results and conclusion, the editorial office will publish corrections in the journal as soon as possible, and detailing the changes made to the original article. If severe scientific errors are found in published articles, or the article is suspected of academic misconduct, such as plagiarism and data falsification, the editorial office will issue a statement to inform readers of the risks, initiate an investigation and announce the final result, or even retract article with a retraction statement if necessary.
Section 6 Submission Method and Fees
1. An article processing fee of 30 yuan is required for submissions, which should be remitted to the editorial office at No. 30 Luojia Road, Nanjing City, and received by Chen Jinfeng (postal code: 210024). After confirming the publication of the manuscript, a notice will be sent to authors and the page charge (400 yuan per page) shall be payable. After the article is published, a remuneration will be offered and 2 copies of the current issue will be posted to the authors
2. All manuscripts accepted by this journal are also published in electronic journals, CD versions, and other forms. The remuneration paid includes electronic journal and CD version remuneration.
3. Submission URL: www.sylnyx.com
